Abstract: A system enables a home operator to establish an automated monitoring process which identifies outage events on competitor wireless networks (e.g., peer operators) operating in the same geographies as home operator. The home operator then is able to selectively offer, in near real-time, to open roaming to the peer operator, or implement roaming automatically based on predefined and mutually agreed upon rule sets. The monitoring process may observe non-customer attach request volumes in order to identify outage events on competitor wireless networks.

Abstract: The present disclosure provides for processes and systems for the purification of alkyl sulfide product streams including dimethyl sulfide (DMS). In some aspects, the disclosure provides for the removal of carbon disulfide (CS2) from DMS via hydrolytic catalysis. In further embodiments, the disclosed catalytic processes are performed using mixed-metal catalyst systems such as cobalt-molybdenum (CoMo) and nickel-molybdenum (NiMo) catalyst systems.

Abstract: Aspects of the subject disclosure may include, for example: determining whether a Subscriber Identify Module (SIM) profile that supports communication via Citizen Band Radio Spectrum (CBRS) is present on a device, resulting in a determination; responsive to the determination being that the SIM profile that supports the communication via the CBRS is present on the device, providing to a user via an interface an element that permits the user to select enabling of communication via the CBRS, disabling of communication via the CBRS, or any combination thereof; receiving from the interface a selection by the user, wherein the selection indicates either an instruction by the user to enable the communication via the CBRS, or an instruction by the user to disable the communication via the CBRS; and responsive to the selection: enabling the communication via the CBRS in a first case that the selection indicates the instruction by the user to enable the communication via the CBRS; or disabling the communication via the

Abstract: A cast structure configured to support a suspension arm and motor mount assembly for a vehicle is disclosed. The cast structure comprises a first fixing point attachable to a first mounting feature of a first crossmember of a vehicle frame, a first feature configured to receive the suspension arm of the vehicle in an assembled configuration, and a first portion configured to support a motor of the vehicle in an assembled configuration.

Abstract: A system enables a home operator to establish an automated monitoring process which identifies outage events on competitor wireless networks (e.g., peer operators) operating in the same geographies as home operator. The home operator then is able to selectively offer, in near real-time, to open roaming to the peer operator, or implement roaming automatically based on predefined and mutually agreed upon rule sets. The monitoring process may observe non-customer attach request volumes in order to identify outage events on competitor wireless networks.

Abstract: In an illustrative embodiment, methods and systems for attenuating effect(s) associated with reduction or cessation of substance use by an individual include providing a neurostimulation delivery system including a neurostimulation device having a first portion including a first electrode configured to electrically stimulate auricular branch(es) of the vagus nerve, and a second portion including a second electrode configured to electrically stimulate branch(es) of the auriculotemporal nerve, and a pulse generator including circuitry configured to deliver therapeutic stimulation pulses to the first and second electrodes. Methods and systems include positioning the neurostimulation device for administration of the neurostimulation treatment, whereby the first electrode is disposed on, over or adjacent to auricular branch(es) of the vagus nerve, and the second electrode is disposed on, over or adjacent to branch(es) of the auriculotemporal nerve, and administering the neurostimulation treatment.

Abstract: Embodiments provide for identifying and resolving conflicts in access permissions migrated data by receiving a set of mappings including path mappings of a hierarchy of data objects on the source system to locations on the target system for migrated data objects. Based on the received set of mappings, permissions controlling access to data objects of the hierarchy of data objects on the source system can be translated to permissions controlling access to the migrated data objects on the target system for one or more user accounts on the target system. One or more conflicts can be detected between permissions on the source system and permissions on the target system. A conflict resolution strategy can be selected from a plurality of conflict resolution strategies and the selected conflict resolution strategy can be applied to the permissions controlling access to the migrated data objects on the target system.

Abstract: In an illustrative embodiment, methods and systems for attenuating effect(s) associated with reduction or cessation of substance use by an individual include providing a neurostimulation delivery system including a neurostimulation device having a first portion including at first electrode configured to electrically stimulate branch(s) of the auriculotemporal nerve, and a second portion including a second electrode configured to electrically stimulate auricular branch(es) of the vagus nerve, and a pulse generator including circuitry configured to deliver therapeutic stimulation pulses to the first and second electrodes. Methods and systems include positioning the neurostimulation device for administration of the neurostimulation treatment, whereby the first electrode is disposed on, over or adjacent to branch(s) of the auriculotemporal nerve, and the second electrode is disposed on, over or adjacent to auricular branch(es) of the vagus nerve, and administering the neurostimulation treatment.

Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor that comprises a protein or peptide tag, such as a SpyCatcher or a SpyTag moiety, bound to an extracellular hinge region, a transmembrane domain, and an intracellular domain for T cell activation.

Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor that comprises a protein or peptide tag, such as a SpyCatcher or a SpyTag moiety, bound to an extracellular hinge region, a transmembrane domain, and an intracellular domain for T cell activation.

Abstract: Systems and methods for treating cognitive dysfunction and/or depression using transcutaneous auricular neurostimulation therapy may include positioning a wearable neurostimulation device about the ear of the patient, connecting the wearable neurostimulation device, to a pulse generator, and delivering a first series of stimulation pulses to at least one first electrode, the first series being configured to increase monoamine neurotransmitter availability, and delivering a second series of stimulation pulses to at least one second electrode, the second series being configured to upregulate opioid receptor agonists.

Abstract: The invention includes a chimeric antigen receptor (CAR) specific for a natural-killer group 2, member D ligand (NKG2DL), compositions comprising the CAR, polynucleotides encoding the CAR, vectors comprising a polynucleotide encoding the CAR, and recombinant T cells comprising the CAR. The invention also includes methods of making a genetically modified T cell expressing a NKG2D-CAR wherein the expressed CAR comprises a NKG2D extracellular domain. The present invention also relates generally to the use of T cells engineered to express a CAR to treat cancer associated with NKG2D.

Abstract: Systems and methods for treating cognitive dysfunction and/or depression using transcutaneous auricular neurostimulation therapy may include positioning a wearable neurostimulation device about the ear of the patient, connecting the wearable neurostimulation device, to a pulse generator, and delivering a first series of stimulation pulses to at least one first electrode, the first series being configured to increase monoamine neurotransmitter availability, and delivering a second series of stimulation pulses to at least one second electrode, the second series being configured to upregulate opioid receptor agonists.

Abstract: Provided herein is an animal model system and uses thereof. In particular, provided herein is an animal model for Neisseria infection and use of such a model in research and screening applications.